Internal Medicine, Gastroenterology · Dothan, AL
NPI
1386769404
Since 2007
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
480 Honeysuckle Rd
Dothan, AL, 36305
Phone (334) 836-1212
Groups this clinician bills Medicare through
Medicare paid, 2024
$524K
26,838 services
Medicare patients, 2024
711
Average age 72
Drug cost, 2024
$1.6M
4,184 prescriptions
Company payments, 2025
$4,109
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paul B Lamb was code J3380 (injection, vedolizumab, intravenous, 1 mg), 11,100 times for 24 patients. In total Paul B Lamb billed 26,838 services in 88 codes, and Medicare paid $524K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-02-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3380 Injection, vedolizumab, intravenous, 1 mg | Office | 11,100 | 24 | $17.49 | $194K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 5,000 | 46 | $0.10 | $513 |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 1,520 | 18 | $24.82 | $38K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 1,492 | 146 | $35.60 | $53K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 874 | 146 | $46.58 | $41K |
| 99214 Office E&M - Established | Office | 348 | 261 | $84.07 | $29K |
| 99204 Office E&M - New | Office | 207 | 207 | $105.39 | $22K |
| 43239 Upper GI Endoscopy | Facility | 134 | 127 | $58.01 | $7,774 |
| 45385 Colonoscopy - Lesion Removal | Facility | 117 | 116 | $176.66 | $21K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 117 | 112 | $12.30 | $1,439 |
| 99454 E&M - Miscellaneous | Office | 78 | 17 | $32.75 | $2,554 |
| 45380 Lower GI Endoscopy - Other | Facility | 78 | 78 | $65.35 | $5,097 |
| 96413 Chemotherapy Administration | Office | 70 | 48 | $82.61 | $5,783 |
| 99457 E&M - Miscellaneous | Office | 70 | 18 | $36.24 | $2,537 |
| J7050 Infusion, normal saline solution, 250 cc | Office | 69 | 48 | $0.47 | $32.54 |
By year: 2022 $344K for 16,163 services; 2023 $483K for 26,093 services; 2024 $524K for 26,838 services.
Medicare prescription drug claims, 2024
In 2024, the drug Paul B Lamb prescribed most often to Medicare patients was Pantoprazole Sodium, with 765 prescriptions and refills. In total Paul B Lamb wrote 4,184 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 765 | 1,689 | 244 | $7,127 |
| Omeprazole Generic | 574 | 1,282 | 217 | $10K |
| Dicyclomine Hcl Generic | 290 | 379 | 95 | $4,928 |
| Linzess Linaclotide | 215 | 337 | 67 | $179K |
| Famotidine Generic | 193 | 467 | 77 | $3,657 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 185 | 185 | 181 | $12K |
| Colesevelam Hcl Generic | 177 | 247 | 43 | $23K |
| Metoclopramide Hcl Generic | 91 | 134 | 28 | $360 |
| Ondansetron Odt Ondansetron | 91 | 93 | 38 | $1,873 |
| Sucralfate Generic | 89 | 112 | 34 | $1,952 |
| Ondansetron Hcl Generic | 74 | 74 | 25 | $751 |
| Trulance Plecanatide | 73 | 109 | 26 | $61K |
| Dexlansoprazole Dr Dexlansoprazole | 68 | 113 | 14 | $17K |
| Spironolactone Generic | 64 | 114 | 17 | $933 |
| Creon Lipase/Protease/Amylase | 56 | 68 | 13 | $154K |
Brand drugs: 783 claims; generic drugs: 3,401 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paul B Lamb $4,109 ($4,109 in general payments such as food, travel and fees) from 24 companies. The largest payer was Genzyme Corporation with $1,417.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 8 | $1,417 |
| Abbvie Inc. ABBV | 37 | $614 |
| Lilly USA, LLC LLY | 12 | $326 |
| Janssen Biotech, Inc. JNJ | 16 | $313 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 7 | $153 |
| Madrigal Pharmaceuticals MDGL | 8 | $148 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 8 | $145 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 7 | $137 |
| Medtronic, Inc. MDT | 3 | $115 |
| Gilead Sciences, Inc. GILD | 6 | $111 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.